Kinetosen

Part of the HNO Praxis Heute book series (HNO, volume 15)

Zusammenfassung

„Panurg, der mit dem Inhalt seines Magens die skatophagen Fische gefüttert hatte, lag jetzt verzagt, jammernd und halbtodt auf dem Verdeck und rief alle Heiligen beiderlei Geschlechts um Hülfe an, schwur, er wolle bei erster Gelegenheit beichten und schrie dann wieder in höchster Bedrängnis.“

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Attias J, Gordon CR, Bolnick A, Sadé J (1987) Nystagmus episodes related to sea sickness. Arch Otorhinolaryngol 244:84–87PubMedCrossRefGoogle Scholar
  2. Bard P, Woolsley CN, Snider RS, Mountcastle VB, Bromiley RB (1947) Delimination of central nervous mechanisms involved in motion sickness. Fed Proc 72:345–347Google Scholar
  3. Baumgarten RJ v, Thümler R, Vogel H (1980). Experimented Untersuchungen über die Wirksamkeit des Metoclopramid bei der Kinetose. Therapiewoche 37:5974Google Scholar
  4. Baumgarten RJ v (1987) General remarks on the role of the vestibular system in weightlessness. Arch Otorhinolaryngol 244:135–142CrossRefGoogle Scholar
  5. Becker G, Goosens H, Seemann K, Souchon F, Weitz T (1984) Kinetoseprophylaxe mit TTS-Scopolamin. DMW 109:1881–1885CrossRefGoogle Scholar
  6. Bick PA (1983) Physiological and psychological correlates of motion sickness. Br J Med Psychol 56:189–196PubMedCrossRefGoogle Scholar
  7. Bruce DG, Golding JF, Hockenhull N, Pethybrigde RJ (1990) Acupressure and motion sickness. Aviat Space Environ Med 61(4): 361–365PubMedGoogle Scholar
  8. Cheung BSK, Money KE, Kohl RL, Kinter LB (1992) Investigation of anti-motion sickness drugs in the squirrel monkey. J Clin Pharmacol 32:163–175PubMedGoogle Scholar
  9. Chüden H (1976) Die Kinetosen. Med Klin 71:689–698PubMedGoogle Scholar
  10. Fischer AJEM, Osterveld WJ (1979) Bewegungskrankheit. HNO 27:285–291PubMedGoogle Scholar
  11. Frenzel H (1961) Ein einfacher Drehstuhlmodellversuch zur Frage der Corioliser- regung der Bogengänge bei Kopfbewegungen während der Drehung. Arch Ohr Nasen Kehlkopfheilkd 177:563CrossRefGoogle Scholar
  12. Graybiel A, Wood CD, Miller EF, Cramer DB (1968) Diagnostic criteria for grading the severity of acute motion sickness. Aerospace Medicine 39(5): 453–455 20 W. DelbPubMedGoogle Scholar
  13. Haid CT (1990) Vestibularisprüfung und vestibulare Erkrankungen. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  14. Helling K, Westhofen M (1994) Experimentaluntersuchungen zur Kinetose an Bord eines Forschungsschiffes. HNO 42:214–219PubMedGoogle Scholar
  15. Holtmann S, Seifert J, Seherer H (1987) Ursachen und Behandlung der Seekrankheit. Laryngol Rhinol Otol 66:99–103CrossRefGoogle Scholar
  16. Holtmann S, Clarke AH, Seherer H, Höhn M (1989) The Anti-motion sickness mechanism of Ginger. Acta Otolaryngol (Stockh) 108:168–174CrossRefGoogle Scholar
  17. Hu S, Stern RM, Koch KL (1992) Electrical acustimulation reliefes vection-induced motion sickness. Gastroenterology 102:1854–1858PubMedGoogle Scholar
  18. Johnson WH (1971) Some otological problems during space flight. J Laryngol Otol 85(12): 1246–1248PubMedCrossRefGoogle Scholar
  19. Kennedy RS, Graybiel A, McDonough RC, Beckwith RD (1968) Symptomatology under storm conditions in the north atlantic in control subjects and in persons with bilateral labyrinthine defects. Acta Otolaryngol 66:533–540PubMedCrossRefGoogle Scholar
  20. Kennedy RS, Fowlkes JE, Berbaum BA, Lilienthal MG (1992) Use of a motion sickness history questionnaire for prediction of simulator sickness. Aviat Space Environ Med 63:588–593PubMedGoogle Scholar
  21. Koch KL, Summy-Long J, Bingman S, Sperry N, Stern RM (1990) Vasopressin and oxytocin responses to illusory self-motion in man. J Clin Endocrinol Metab 71:1269–1275PubMedCrossRefGoogle Scholar
  22. Kohl RL, MacDonald S (1991) New pharmacologic approaches to the prevention of space/motion sickness. J Clin Pharmacol 31:934–946PubMedGoogle Scholar
  23. Lawther A, Griffin MJ (1987) Prediction of the incidence of motion sickness from the magnitude, frequency and duration of vertical oscillation. J Acoust Soc Am 82:957–966PubMedCrossRefGoogle Scholar
  24. Lieven T v (1970) Symptomgenese und Therapie der Reisekrankheit. MMW 43:1953–1959Google Scholar
  25. Lieven T v, Voigt K (1971) Vergleichsuntersuchungen über die Wirksamkeit von zwei Antiemetika bei experimentell erzeugten Kinetosen. Med Klin 66:1089–1093Google Scholar
  26. Lisberger SG, Fuchs AF (1978) Role of primate flocculus during rapid behavioral modification of vestibular-ocular reflex. J Neurophysiol 41:733–763PubMedGoogle Scholar
  27. Lucot JB, Crampton GH (1986) Xylazine emesis, yohimbine and motion sickness. Susceptibility in the cat. J Pharmacol Exp Ther 237:450–455PubMedGoogle Scholar
  28. Lucot JB, Crampton GH, Matson WR, Gamache PH (1989) Cerebrospinal fluid constituents of cat vary with susceptibility to motion sickness. Life Sci 44:1239–1245PubMedCrossRefGoogle Scholar
  29. Mark H (1983) Über die Ursachen des Erbrechens bei der Seekrankheit. Laryngol Rhinol Otol 62:317–319CrossRefGoogle Scholar
  30. Mergighiani D, Martini A (1980) Motion sickness and space sickness: clinical and experimental findings. ORL 42:185–195CrossRefGoogle Scholar
  31. Morrow GR (1984) Susceptibility to motion sickness and chemotherapy-induced side-effects. Lancet: 390–391Google Scholar
  32. Mowrey DB, Clayson DE (1982) Motion sickness, ginger and psychophysies. Lancet: 655–657Google Scholar
  33. Müller M, Besch W, Steilner D (1987) Kinetoseprophylaxe bei Kindern. Fortschr Med 105(4): 82–87PubMedGoogle Scholar
  34. Offenloch K, Zahner G, Dietlein G, Franz I (1986) Vergleichende Inflight-Untersuchungen eines Scopolamin-haltigen Membranpflasters versus Dimenhydrat unter definierten Beschleunigungsreizen. Drug Res 36(11): 1401–1406Google Scholar
  35. Osterholm RK, Camoriano JK (1982) Transdermal scopolamine psychosis. JAMA 247:3081PubMedCrossRefGoogle Scholar
  36. Petrin A (1974) Bewegungskrankheit und ihre Therapie/Eine Übersicht. Schweiz Rundsch Med Prax 63:79–81PubMedGoogle Scholar
  37. Pfaltz CR (1987) The vestibular system in weightlessness. Arch Otorhinolaryngol 244:133–134PubMedCrossRefGoogle Scholar
  38. Reason JT (1978) Motion sickness adaptation: a neural mismatch model. J R Soc Med 71:819–829PubMedGoogle Scholar
  39. Reimann HJ, Erbel F, Bergemann B (1981) Fortschritt in der Therapie der Reise- krankheit: das dimenhydrathaltige Kaugummidragee. Ther d Gegenw 120:1171–1180Google Scholar
  40. Schadewaldt H (1967) Zur Geschichte der Seekrankheit. Med Welt 38:2258–2265PubMedGoogle Scholar
  41. Scherer H (1982) Die räumliche Orientierung. MMW 124:261–267Google Scholar
  42. Scherer H (1994) Prädispostion und Therapie von Kinetosen. HNO 52:202–203Google Scholar
  43. Scherer H, Bschorr J (1980) Betrachtungen zur Wirksamkeitsmessung antivertiginöser Medikamente anhand zweier Standardpräparate und eines neu entwikkelten Psychopharmakons. Laryngol Rhinol 59:477–484CrossRefGoogle Scholar
  44. Shojaku H, Watanabe Y, Ito M, Mizukoshi K, Kazuyoshi Y, Sekigushi C (1993) Effect of transdermally administered scopolamine on the vestibular system in humans. Acta Otolaryngol [Suppl] (Stockh) 504:41–45CrossRefGoogle Scholar
  45. Shupak A, Gordon CR, Spitzer O, Mendelowitz N, Melamed Y (1989) Three- years experience of transdermal scopolamine: long-term effectiveness and side effects. Pharmatherapeutika 5:365–371Google Scholar
  46. Shupak A, Kerem D, Gordon C et al. (1990) Vestibulo-ocular reflex as a parameter of seasickness susceptibility. Ann Otol Rhinol Laryngol 99:131–136PubMedGoogle Scholar
  47. Takeda N, Morita M, Kubo T et al. (1986) Histaminergic mechanism of motion sickness. Acta Otolaryngol (Stockh) 101:416–421CrossRefGoogle Scholar
  48. Uijtdehaage SHJ, Stern RM, Koch KL (1992) Effects of eating on vection-induced motion sickness, cardiac vagal tone, and gastric myoelectric activity. Psycho- physiology 29(2): 193–201Google Scholar
  49. Vogel H, Kohlhaas R, Baumgarten RJ v (1982) Dependence of motion sickness in automobiles on the direction of linear acceleration. Eur J Appl Physiol 48:399–405CrossRefGoogle Scholar
  50. Wang SC, Chinn HL (1956) Experimental motion sickness in dogs: importance of labyrinth and vestibular cerebellum. Am J Physiol 185:614Google Scholar
  51. Wood CD, Graybiel A (1968) Evaluation of sixteen anti motion sickness drugs under controlled laboratory conditions. Aerospace Med 39:1341–1344PubMedGoogle Scholar
  52. Wood CD, Kennedy RE, Graybiel A, Trumbull R, Wherry RJ (1966) Clinical effectiveness of anti-motion-sickness drugs-computer. Review of the literature. JAMA 198:133–136CrossRefGoogle Scholar
  53. Wood CD, Steward J J, Wood MJ, Mims M (1992) Effectiveness and duration of intramuscular antimotion sickness medications. J Clin Pharmacol 32:1008–1012PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • W. Delb

There are no affiliations available

Personalised recommendations